Patient Education Sheet Library
Search Results
Nivolumab and FOLFOX
The combination of nivolumab and FOLFOX (leucovorin, fluorouracil (5-FU), and oxaliplatin) is used for stomach…
Treatment Given by InfusionDownloads
Download (English) – 0.82MBTrastuzumab and FOLFOX
Trastuzumab and FOLFOX is used for stomach cancer and esophageal cancer.
Treatment Given by InfusionBevacizumab and FOLFOX
Oxaliplatin, Leucovorin, Fluorouracil (FOLFOX), and Bevacizumab is used to treat colon cancer.
Treatment Given by InfusionDownloads
Tislelizumab and FOLFOX
The combination of tislelizumab and FOLFOX (leucovorin, fluorouracil (5-FU), and oxaliplatin) is used for stomach…
Treatment Given by InfusionDownloads
Pembrolizumab, Trastuzumab and FOLFOX
Pembrolizumab, trastuzumab, and FOLFOX is used for stomach cancer and esophageal cancer.
Treatment Given by InfusionDownloads
Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX)
The combination of leucovorin, fluorouracil (5-FU), and oxaliplatin (FOLFOX) is used for many types of…
Treatment Given by InfusionDownloads
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
